The State of the Art in Internal Medicine
Innovations and New Practices in Internal Medicine 2023 will be held online this year, using live streaming, electronic Q&A, and other remote learning technologies.
Overview
This program provides a comprehensive update of the most important changes now impacting Internal Medicine and guidance on how to incorporate these changes into your clinical practice to improve patient outcomes.
Practical, Fast-Paced, Online Education
This live streaming educational experience is fast paced, relevant to the current healthcare environment, and draws upon real-life cases. The course is designed and led by Harvard Medical School’s clinical faculty who are leaders in their respective fields and are instrumental in bringing these novel developments to clinical medicine. It offers updates and advances in diagnostic and treatment approaches, covering the broad spectrum of internal medicine specialties:
Cardiovascular Medicine
Pulmonology
Oncology
Dermatology
Addiction Medicine
Endocrinology
Geriatrics
Rheumatology
Gastroenterology
Neurology
Infectious Diseases
Nephrology
Allergy/Immunology
Women’s Health
Psychiatry
Guidance to Improve Diagnosis, Treatment, and Clinical Outcomes
Highlights of this program include:
Important updates on emerging viruses and guidance on vaccines
Comprehensive updates on new anticoagulants and their antidotes
Algorithms for the use of diabetes medications
Care of the LGBTQ patient
Medical and surgical therapy for obesity management
Latest developments on the use of SGLT-2 inhibitors in heart failure
Advances in percutaneous aortic and mitral valve therapies
Novel therapies for lipid management
Recognizing dermatologic conditions in skin of color
Up-to-date guidance for management of opioid addiction
Optimal management of irritable bowel syndrome
The latest in cancer screening and what the internist needs to know about cancer immunotherapy
Emerging therapies for Alzheimer’s disease and depression
Best practices for responsible antibiotic use
Update in non-alcoholic fatty liver disease
For full agenda, click here.